{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-009564","form_type":"8-K","ticker":"CVM","cik":"0000725363","company_name":"CEL SCI CORP","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.716664+00:00","generated_at":"2026-05-31T15:49:52.739227+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CEL-SCI closes $10.8M public offering of common stock and pre-funded warrants","bullets":["Gross proceeds of $10,845,000 from offering of 10,845,000 shares/common stock or pre-funded warrants at $1.00/share.","Net proceeds to fund continued development of lead cancer drug Multikine and for general corporate purposes.","Offering closed on July 29, 2024; ThinkEquity acted as sole placement agent.","Officers and directors subject to 90-day lock-up on company securities.","Pre-funded warrants exercisable at $0.01 per share and expire when fully exercised."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-009564","json":"https://secwatch.observer/filing/0001654954-24-009564.json","markdown":"https://secwatch.observer/filing/0001654954-24-009564.md","text":"https://secwatch.observer/filing/0001654954-24-009564.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/725363/000165495424009564/0001654954-24-009564-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/725363/000165495424009564/cvm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:49:52.739227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}